Prosarix Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 3

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Prosarix General Information

Description

Provider of contract research services to the healthcare sector. The company offers computational approaches and products for the identification and optimization of small molecules and proteins and assists in various aspects of drug discovery, thereby offering clients flexible treatment of proteins and solvents.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Discovery Tools (Healthcare)
Parent Company
Corporate Office
  • Moneta B280
  • Babraham Research Park
  • Cambridge CB22 3AT
  • England, United Kingdom
+44 01223 000000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prosarix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prosarix‘s full profile, request access.

Request a free trial

Prosarix Patents

Prosarix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-0810168-D0 Novel serotonergic modulators Inactive 04-Jun-2008
US-8748182-B2 Mutant proteins and methods for producing them Active 08-Dec-2007 0000000000 00
US-20110028700-A1 Mutant proteins and methods for producing them Active 08-Dec-2007 0000000000 00
GB-0715378-D0 Novel serotonergic modulators Inactive 07-Aug-2007
GB-0814351-D0 Novel serotonergic modulators Active 07-Aug-2007 C07D249/12
To view Prosarix’s complete patent history, request access »

Prosarix Executive Team (3)

Name Title Board Seat
Jonathan Heal Ph.D Co-Founder & Chief Scientific Officer
William Hamilton Ph.D Co-Founder & Director
Joe Sheridan Ph.D Director of Drug Discovery
To view Prosarix’s complete executive team members history, request access »

Prosarix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prosarix FAQs

  • When was Prosarix founded?

    Prosarix was founded in 2007.

  • Who is the founder of Prosarix?

    Jonathan Heal Ph.D and William Hamilton Ph.D are the founders of Prosarix.

  • Where is Prosarix headquartered?

    Prosarix is headquartered in Cambridge, United Kingdom.

  • What is the size of Prosarix?

    Prosarix has 3 total employees.

  • What industry is Prosarix in?

    Prosarix’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Prosarix a private or public company?

    Prosarix is a Private company.

  • What is Prosarix’s current revenue?

    The current revenue for Prosarix is 00000.

  • When was Prosarix acquired?

    Prosarix was acquired on 05-Feb-2019.

  • Who acquired Prosarix?

    Prosarix was acquired by RxCelerate and Evolva.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »